A researcher with Sinovac Biotech Company begins preparation work to manufacture an A/H1N1 influenza vaccine for human use using the NYMCX-179A flu virus on June 8. Sinovac Biotech Company, a vaccine-focused biotech company in China, began manufacturing the vaccine on Monday after receiving flu strain samples from the World Health Organization (XINHUA) |